https://www.ibtomato.com/ExternalView.aspx?type=1&no=19443IB토마토ko2026-09-04T17:30:05+09:00KRX·NXT 동시 운영인데…증권사 인력은 '그대로'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19440IB토마토ko2026-09-04T16:53:42+09:00JW중외제약, 1100억 들여 비만약 승부…후발주자 한계 넘을까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19439IB토마토ko2026-09-04T16:42:37+09:00(IPO인사이트)티앤이코리아, 흑자전환·자본잠식 해소…코스닥 도전https://www.ibtomato.com/ExternalView.aspx?type=1&no=19441IB토마토ko2026-09-04T16:34:50+09:00(Deal모니터)롯데오토리스, 단기 CP 300억 장기채로 갈아탄다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19438IB토마토ko2026-09-04T16:09:12+09:00(크레딧시그널)JB우리캐피탈, 수익성은 탄탄한데 건전성은 흔들https://www.ibtomato.com/ExternalView.aspx?type=1&no=19414IB토마토ko2026-09-02T18:01:13+09:00SK이터닉스, 솔라닉스 5곳 모두 장부가 0원…투자 회수 '빨간불'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19417IB토마토ko2026-09-02T17:52:04+09:00코윈테크, 로봇기업 간판 달았지만…현금성자산 반토막https://www.ibtomato.com/ExternalView.aspx?type=1&no=19405IB토마토ko2026-09-02T17:41:13+09:00(3% 금리의 명암)①대출금리 먼저 뛰었다…은행권 NIM '청신호'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19406IB토마토ko2026-09-02T17:03:28+09:00대풍산업, 준공 후에도 차입 확대…대부업서 90억 조달https://www.ibtomato.com/ExternalView.aspx?type=1&no=19426IB토마토ko2026-09-03T17:46:13+09:00에코프로비엠, 유증 규모 26% 축소…국내 투자재원 2850억 '공백'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19404IB토마토ko2026-09-02T15:46:01+09:00(약국 지각변동)②브랜드보다 가격표…제약사 '진열 경쟁' 불붙었다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19423IB토마토ko2026-09-02T19:02:13+09:00SK에코플랜트의 계산된 손절…500억 잃고 7058억 부담 넘겼다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19399IB토마토ko2026-09-01T18:49:51+09:00CJ씨푸드, 금융비용도 못 버는 구조…'영업통' 김동환 구원투수